Similar Articles
31 Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease
32 Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis
33 Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma
34 Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagy
35 Global scientific trends on hepatocellular carcinoma research from 2004 to 2023: A bibliometric and visualized analysis
36 Preoperative model for predicting early recurrence in hepatocellular carcinoma patients using radiomics and deep learning: A multicenter study
37 Development and validation of a nomogram for predicting postoperative venous thromboembolism risk in patients with hepatocellular carcinoma
38 Transarterial chemoembolization combined with lenvatinib vs transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
39 Regulator of chromosome condensation 1 promotes hepatocellular carcinoma proliferation via cell-division-cycle-associated-8 dependent phosphoinositide 3-kinase/protein kinase B signaling
40 Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA